Literature DB >> 9713707

Inhibition of lung surfactant secretion by KN-62, a specific inhibitor of the calcium- and calmodulin-dependent protein kinase II.

L Liu1.   

Abstract

A role of Ca(2+)- and calmodulin-dependent protein kinase II (CaMK II) in lung surfactant secretion was evaluated using KN-62, a specific inhibitor of CaMK II. KN-62 caused a dose-dependent inhibition of Ca2+ iononphore A23187-stimulated phosphatidylcholine (PC) secretion from cultured alveolar type II cells. Concentration effecting 50% inhibition was approximately 4 microM. However, KN-62 only slightly influenced PC secretion from type II cells stimulated by phorbol 12-myristate 13-acetate, terbutaline and ATP that are known to increase surfactant secretion via the protein kinase C and protein kinase A pathways. KN-62 also inhibited the activity of CaMK II in type II cells. A 55 kDa protein was detected in type II cells by Western blot analysis using an antibody against the beta-subunit of CaMK II. The results suggest that CaMK II participates in A23187-stimulated lung surfactant secretion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9713707     DOI: 10.1080/15216549800203252

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  3 in total

1.  Epithelial Gpr116 regulates pulmonary alveolar homeostasis via Gq/11 signaling.

Authors:  Kari Brown; Alyssa Filuta; Marie-Gabrielle Ludwig; Klaus Seuwen; Julian Jaros; Solange Vidal; Kavisha Arora; Anjaparavanda P Naren; Kathirvel Kandasamy; Kaushik Parthasarathi; Stefan Offermanns; Robert J Mason; William E Miller; Jeffrey A Whitsett; James P Bridges
Journal:  JCI Insight       Date:  2017-06-02

2.  Orphan G protein-coupled receptor GPR116 regulates pulmonary surfactant pool size.

Authors:  James P Bridges; Marie-Gabrielle Ludwig; Matthias Mueller; Bernd Kinzel; Atsuyasu Sato; Yan Xu; Jeffrey A Whitsett; Machiko Ikegami
Journal:  Am J Respir Cell Mol Biol       Date:  2013-09       Impact factor: 6.914

Review 3.  The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases.

Authors:  Zeeshan Sattar; Alnardo Lora; Bakr Jundi; Christopher Railwah; Patrick Geraghty
Journal:  Pulm Med       Date:  2021-06-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.